At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96 enrolled
Drug / intervention
Chartis System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) in Subjects With Heterogeneous Emphysema
In Brief
A clinical study evaluating Chartis System and Endobronchial Valve (EBV) Treatment for Emphysema. Completed, enrolled 96 participants across 2 sites in 2 countries.
Detailed Summary
Use of the Chartis® Assessment System prior to EBV Treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEmphysema
CountriesGermany, Netherlands
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartJan 2012
Primary CompletionMar 2013
TodayJul 2026
First PostedApr 12, 2010
Enrollment StartJan 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.2 years ago
Interventions
Chartis Systemdevice
The Chartis System provides a value that represents the quantification of the average resistance to airflow through collateral airways.
Endobronchial Valve (EBV) Treatmentdevice
The endobronchial valve is designed to induce target lobe volume reduction.